Blog Read the latest perspectives from our team of subject matter experts and others How Incyte Is Advancing Clinical Trial RepresentationClinical trial representation is more than just a regulatory requirement—it’s a critical component of accessible healthcare. Ensuring that trial participants reflect the real-world patient population leads to more effective… Continue reading → Read the article Post Topics:Artificial Intelligence Commercialization Drug Development Global Impact HCP Volunteers KOL Engagement Patient Representation Provider Data Research Post Industries:Commercialization Global Impact Health Plans & Digital Health Pharmaceutical & Biotechnology Provider Data Research Drug DevelopmentPatient RepresentationFour Strategies for Preparing FDA DAPsIn the race to bring new treatments and cures to market, clinical trial operations and feasibility teams often face a formidable challenge: ensuring that patient populations are accurately represented… Continue reading → Read the articleno Drug DevelopmentPatient Representation3 Ways CROs Can Expedite Clinical Trial Site SuccessClinical Research Organizations (CROs) play an important role in the success of clinical trials. They provide crucial resources, processes, and strategies to ensure that trials are conducted with the… Continue reading → Read the articleno KOL EngagementLet’s Get Personal: Four Benefits to Omnichannel StrategiesWith the proliferation of digital media, marketing in the healthcare industry has shifted from traditional tactics to an omnichannel approach. Omnichannel engagement for physician marketing is a powerful tool… Continue reading → Read the articleno KOL EngagementNurses: The Unsung Heroes in Pharma and BiotechHealthcare providers are often the first line of defense in ensuring that people receive the medical treatment they need. But nurses are often overlooked as a solution to addressing patient… Continue reading → Read the articleno KOL EngagementPatient RepresentationFour Ideas for Pharma to Maximize the Influence of Digital Opinion Leaders in MedicinePharmaceutical companies have long recognized the importance of engaging key opinion leaders (KOLs) to gain insight and support for clinical research, drug development, and medical education. With the rise… Continue reading → Read the articleno Drug DevelopmentPatient RepresentationData Networks & Guiding Clinical Trials – Six Metrics for Powering Trials to Reach Vulnerable Patient PopulationsFor clinical operations and development clinical feasibility teams, and patient representation leaders, as well as health economics and outcomes research (HEOR) teams, it is essential to understand the considerations when… Continue reading → Read the articleno«‹3456789›»
